Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022

August 12, 2021

Biotechnology

Silo Wellness Secures Right of First Refusal on All Psilocybin Mushroom Biomass from Medford, Oregon First-Mover Satya; Other Corporate Updates

March 24, 2023
Genprex CEO Commends FDA’s Initiative to Accelerate Approval Process for Gene Therapies

March 23, 2023
Evofem Biosciences Announces Cost Reduction Measures

March 21, 2023
Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use Disorder

March 21, 2023